Limited Liability Company «RDIF Asset Management» – Trademark Portfolio

Entity Type: 16

Limited Liability Company «RDIF Asset Management» holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include SPUTNIK V THE FIRST REGISTERED COVID-19 VACCINE PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY and SPUTNIK VACCINE THE FIRST REGISTERED COVID-19 VACCINE PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY.

Presnenskaya embankment, 8, building 1,

floor 7, compartment I, part of the room3 RU-123112 Moscow

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Limited Liability Company «RDIF Asset Management»'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Limited Liability Company «RDIF Asset Management» have?

Limited Liability Company «RDIF Asset Management» has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Limited Liability Company «RDIF Asset Management» file in?

Limited Liability Company «RDIF Asset Management» files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Limited Liability Company «RDIF Asset Management»'s most well-known trademarks?

Limited Liability Company «RDIF Asset Management»'s registered trademark portfolio includes well-known marks such as SPUTNIK V THE FIRST REGISTERED COVID-19 VACCINE PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY and SPUTNIK VACCINE THE FIRST REGISTERED COVID-19 VACCINE PROVEN HUMAN ADENOVIRAL VECTOR TECHNOLOGY. These are among 2 currently registered trademarks in the portfolio.

What is Limited Liability Company «RDIF Asset Management»'s trademark registration success rate?

Limited Liability Company «RDIF Asset Management» has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.